Literature DB >> 23617653

Biliary self-expandable metallic stent for unresectable malignant distal biliary obstruction: which is better: covered or uncovered?

Hiroyuki Isayama1, Yousuke Nakai, Hirofumi Kogure, Natsuyo Yamamoto, Kazuhiko Koike.   

Abstract

Self-expandable metallic stents (SEMS) are a widely accepted biliary endoprosthesis for patients with unresectable malignant distal biliary obstruction. There are two types of SEMS: covered and uncovered. Uncovered SEMS (UCSEMS) embed into the biliary wall due to their mesh structure and self-expandability, and are resistant to migration. However, the disadvantage of UCSEMS is occlusion due to tumor ingrowth (TI) via the stent mesh, and TI is the main cause of UCSEMS occlusion. To overcome this, covered SEMS (CSEMS) were developed and showed longer patency than UCSEMS. However, migration due to the non-embedded stent body is the main cause of CSEMS dysfunction. There are some randomized studies comparing CSEMS and UCSEMS; however, the results are different according to each study. From one meta-analysis, CSEMS showed longer patency than UCSEMS. A literature review revealed that covered SEMS showed longer patency than UCSEMS. Some studies cannot clearly demonstrate the superiority of CSEMS, as the CSEMS used did not prevent TI or migration. Mechanical properties of SEMS may influence the occurrence of complications. A recent clinical study comparing the Covered Wallstent and the Covered WallFlex revealed superiority of the WallFlex for the prevention of migration. Reducing the axial force and increasing the radial force may lead to good results. Migration of CSEMS should be prevented by taking into consideration the mechanical properties of stents and development of anti-migration systems.
© 2013 The Authors. Digestive Endoscopy © 2013 Japan Gastroenterological Endoscopy Society.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23617653     DOI: 10.1111/den.12078

Source DB:  PubMed          Journal:  Dig Endosc        ISSN: 0915-5635            Impact factor:   7.559


  11 in total

Review 1.  Association between Helicobacter spp. infections and hepatobiliary malignancies: a review.

Authors:  Fany Karina Segura-López; Alfredo Güitrón-Cantú; Javier Torres
Journal:  World J Gastroenterol       Date:  2015-02-07       Impact factor: 5.742

Review 2.  Current status of preoperative biliary drainage.

Authors:  Junko Umeda; Takao Itoi
Journal:  J Gastroenterol       Date:  2015-07-03       Impact factor: 7.527

Review 3.  Covered versus uncovered self-expandable metal stents for malignant biliary strictures: A meta-analysis and systematic review.

Authors:  Harsha Moole; Matthew L Bechtold; Micheal Cashman; Fritz H Volmar; Sonu Dhillon; David Forcione; Deepak Taneja; Srinivas R Puli
Journal:  Indian J Gastroenterol       Date:  2016-08-27

Review 4.  Endoscopic management of biliary strictures after living donor liver transplantation.

Authors:  Takeshi Tsujino; Hiroyuki Isayama; Hirofumi Kogure; Tatsuya Sato; Yousuke Nakai; Kazuhiko Koike
Journal:  Clin J Gastroenterol       Date:  2017-06-09

Review 5.  Covered Stents versus Uncovered Stents for Unresectable Malignant Biliary Strictures: A Meta-Analysis.

Authors:  Ming-Yu Chen; Jia-Wei Lin; He-Pan Zhu; Bin Zhang; Guang-Yi Jiang; Pei-Jian Yan; Xiu-Jun Cai
Journal:  Biomed Res Int       Date:  2016-03-16       Impact factor: 3.411

6.  Endoscopic Ultrasound-Guided Biliary Drainage Using Self-Expandable Metal Stent for Malignant Biliary Obstruction.

Authors:  Lei Lu; Xiaowei Tang; Hangbin Jin; Jianfeng Yang; Xiaofeng Zhang
Journal:  Gastroenterol Res Pract       Date:  2017-04-04       Impact factor: 2.260

7.  Prognostic value of inflammation-based markers in patients with recurrent malignant obstructive jaundice treated by reimplantation of biliary metal stents: A retrospective observational study.

Authors:  Hao Jin; Qing Pang; Huichun Liu; Zongkuang Li; Yong Wang; Yimin Lu; Lei Zhou; Hongtao Pan; Wei Huang
Journal:  Medicine (Baltimore)       Date:  2017-01       Impact factor: 1.889

8.  Phase I/II Study: Experience with the Late Onset of Acute Pancreatitis after the Start of Chemotherapy with Gemcitabine Plus nab-Paclitaxel for Metastatic Pancreatic Cancer.

Authors:  Makoto Ueno; Fumio Nagashima; Hideki Ueno; Masafumi Ikeda; Shinichi Ohkawa; Nobumasa Mizuno; Tatsuya Ioka; Yasushi Omuro; Takako Eguchi Nakajima; Junji Furuse
Journal:  Intern Med       Date:  2019-06-27       Impact factor: 1.271

9.  Antireflux Metal Stent for Initial Treatment of Malignant Distal Biliary Obstruction.

Authors:  Shinichi Morita; Yasuaki Arai; Shunsuke Sugawara; Miyuki Sone; Yasunari Sakamoto; Takuji Okusaka; Shigetaka Yoshinaga; Yutaka Saito; Shuji Terai
Journal:  Gastroenterol Res Pract       Date:  2018-01-31       Impact factor: 2.260

10.  Stent insertion with high-intensity focused ultrasound ablation for distal biliary obstruction secondary to pancreatic carcinoma.

Authors:  Shu-Ying Yang; Fen Liu; Yi Liu; Feng-Fei Xia; Yu-Fei Fu
Journal:  Medicine (Baltimore)       Date:  2020-02       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.